FDA approves Emrosi for rosacea in adults
The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in...
Read moreDetailsLatest Post
Dehumanising Malawi hospitals fail mothers with impairments
More than 1.7 million people in Malawi live with disabilities, but the hospital system is not set up for them,...
Read moreDetails
Climatologists Shocked By Nature Op-Ed Arguing Objectivity In Climate Science Is Problematic
Three climate researchers took to the pages of Nature to argue that objectivity in climate science is problematic because it hinders their...
Read moreDetails
How the nation's largest oxygen distributor became a multibillion-dollar Medicare scofflaw
Decades of Misbehavior: Lincare has repeatedly landed on Medicareâ€s equivalent of probation; the company has a dismal history of exploiting...
Read moreDetails
How the UK can aid the GCC to harness EdTech for inclusive learning
Image credit: Getty Images There is a growing market in the Gulf Cooperation Countries (GCC) for UK education, with a...
Read moreDetails
